April 25 (Reuters) - Valeant Pharmaceuticals (NYSE:VRX) International
Inc VRX.TO
* Valeant names Joseph C. Papa to be chairman and chief
executive officer of Valeant Pharmaceuticals
* Says Papa is expected to join Valeant by early May
* Papa, who will also join Valeant's board of directors,
will succeed Michael Pearson (LON:PSON)
* Papa will succeed J. Michael Pearson, who is expected to
remain as CEO and a director until Mr. Papa arrives at Valeant
* Says PAPA will join Valeant from Perrigo Company Plc
Source text for Eikon: ID:nCNWkdqjJa
Further company coverage: VRX.TO